99 related articles for article (PubMed ID: 23462459)
1. Excess body weight and increased Breslow thickness in melanoma patients: a retrospective study.
de Giorgi V; Gori A; Papi F; Grazzini M; Rossari S; Verdelli A; Crocetti E; Savarese I; Giorgi L; Massi D
Eur J Cancer Prev; 2013 Sep; 22(5):480-5. PubMed ID: 23462459
[TBL] [Abstract][Full Text] [Related]
2. The thickness of melanomas has decreased in central Italy, but only for thin melanomas, while thick melanomas are as thick as in the past.
Crocetti E; Caldarella A; Chiarugi A; Nardini P; Zappa M
Melanoma Res; 2010 Oct; 20(5):422-6. PubMed ID: 20679908
[TBL] [Abstract][Full Text] [Related]
3. Epidemiological changes in cutaneous melanoma: retrospective study of 969 cases (1996-2010).
Avilés-Izquierdo JA; Lázaro-Ochaita P; Suárez-Fernández R; Márquez-Rodas I; Parra-Blanco V; Escat-Cortés JL
Rev Clin Esp (Barc); 2013 Mar; 213(2):81-7. PubMed ID: 22874464
[TBL] [Abstract][Full Text] [Related]
4. Symptoms and signs of primary melanoma: important indicators of Breslow depth.
Negin BP; Riedel E; Oliveria SA; Berwick M; Coit DG; Brady MS
Cancer; 2003 Jul; 98(2):344-8. PubMed ID: 12872355
[TBL] [Abstract][Full Text] [Related]
5. Anthropometric factors and Breslow thickness: prospective data on 2570 cases of cutaneous melanoma in the population-based Janus Cohort.
Stenehjem JS; Veierød MB; Nilsen LT; Ghiasvand R; Johnsen B; Grimsrud TK; Babigumira R; Støer NC; Rees JR; Robsahm TE
Br J Dermatol; 2018 Sep; 179(3):632-641. PubMed ID: 29858512
[TBL] [Abstract][Full Text] [Related]
6. Changes from mid-1980s to late 1990s among clinical and demographic correlates of melanoma thickness.
Crocetti E; Carli P
Eur J Dermatol; 2003; 13(1):72-5. PubMed ID: 12609787
[TBL] [Abstract][Full Text] [Related]
7. The role of general practitioners in diagnosis of cutaneous melanoma: a population-based study in France.
Grange F; Barbe C; Mas L; Granel-Brocard F; Lipsker D; Aubin F; Velten M; Dalac S; Truchetet F; Michel C; Mitschler A; Arnoult G; Buemi A; Dalle S; Reuter G; Bernard P; Woronoff AS; Arnold F
Br J Dermatol; 2012 Dec; 167(6):1351-9. PubMed ID: 22834687
[TBL] [Abstract][Full Text] [Related]
8. A ten-year analysis of demographic trends for cutaneous melanoma: analysis of 2501 cases treated at the University Department of Dermatology in Vienna (1990-1999).
Kittler H; Binder M; Wolff K; Pehamberger H
Wien Klin Wochenschr; 2001 Apr; 113(9):321-7. PubMed ID: 11388077
[TBL] [Abstract][Full Text] [Related]
9. Anthropometric factors and risk of melanoma in women: a pooled analysis.
Olsen CM; Green AC; Zens MS; Stukel TA; Bataille V; Berwick M; Elwood JM; Gallagher R; Holly EA; Kirkpatrick C; Mack T; Østerlind A; Rosso S; Swerdlow AJ; Karagas MR
Int J Cancer; 2008 Mar; 122(5):1100-8. PubMed ID: 17990316
[TBL] [Abstract][Full Text] [Related]
10. Does use of estrogens decrease the Breslow thickness of melanoma of the skin? Oral contraceptives and hormonal replacement therapy.
Koomen ER; Joosse A; Herings RM; Casparie MK; Guchelaar HJ; Nijsten T
Melanoma Res; 2009 Oct; 19(5):327-32. PubMed ID: 19593232
[TBL] [Abstract][Full Text] [Related]
11. Biology of desmoplastic melanoma: a case-control comparison with other melanomas.
Livestro DP; Muzikansky A; Kaine EM; Flotte TJ; Sober AJ; Mihm MC; Michaelson JS; Cosimi AB; Tanabe KK
J Clin Oncol; 2005 Sep; 23(27):6739-46. PubMed ID: 16170181
[TBL] [Abstract][Full Text] [Related]
12. Thick melanoma: the challenge persists.
Murray CS; Stockton DL; Doherty VR
Br J Dermatol; 2005 Jan; 152(1):104-9. PubMed ID: 15656809
[TBL] [Abstract][Full Text] [Related]
13. Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy?
Mays MP; Martin RC; Burton A; Ginter B; Edwards MJ; Reintgen DS; Ross MI; Urist MM; Stromberg AJ; McMasters KM; Scoggins CR
Cancer; 2010 Mar; 116(6):1535-44. PubMed ID: 20108306
[TBL] [Abstract][Full Text] [Related]
14. Role of BMI and hormone therapy in melanoma risk: a case-control study.
De Giorgi V; Gori A; Savarese I; D'Errico A; Scarfì F; Papi F; Maio V; Covarelli P; Massi D; Gandini S
J Cancer Res Clin Oncol; 2017 Jul; 143(7):1191-1197. PubMed ID: 28289899
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological analysis of 1571 cutaneous malignant melanomas in Valencia, Spain: factors related to tumour thickness.
Nagore E; Oliver V; Botella-Estrada R; Moreno-Picot S; Guillén C; Fortea JM
Acta Derm Venereol; 2006; 86(1):50-6. PubMed ID: 16585990
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors in young women with cutaneous melanoma.
Burton AL; Egger ME; Quillo AR; Stromberg AJ; Hagendoorn L; Scoggins CR; Martin RC; McMasters KM; Callender GG
Am J Surg; 2014 Jan; 207(1):102-8. PubMed ID: 24330977
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous melanoma in New Zealand: 2000-2004.
Liang JJ; Robinson E; Martin RC
ANZ J Surg; 2010 May; 80(5):312-6. PubMed ID: 20557503
[TBL] [Abstract][Full Text] [Related]
18. A single centre melanoma thickness trend (1985-2009) in relation to skin areas accessible and non-accessible to self-inspection.
Rubegni P; Rossi S; Nami N; Risulo M; Biagioli M; Miracco C; Fimiani M
Australas J Dermatol; 2012 Feb; 53(1):32-6. PubMed ID: 22309328
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic predictors of sentinel lymph node metastasis in thin melanoma.
Han D; Zager JS; Shyr Y; Chen H; Berry LD; Iyengar S; Djulbegovic M; Weber JL; Marzban SS; Sondak VK; Messina JL; Vetto JT; White RL; Pockaj B; Mozzillo N; Charney KJ; Avisar E; Krouse R; Kashani-Sabet M; Leong SP
J Clin Oncol; 2013 Dec; 31(35):4387-93. PubMed ID: 24190111
[TBL] [Abstract][Full Text] [Related]
20. Invasive cutaneous melanoma in The Netherlands, 1989-1990.
Tersmette AC; Coebergh JW; Casparie-van Velsen IJ; Ruiter DJ; van der Rhee HJ; Welvaart K
Eur J Cancer Prev; 1996 Feb; 5(1):69-74. PubMed ID: 8664813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
